Home › Funds › Catalio Capital Management, LP › RYTM

Catalio Capital Management, LP position in RYTM

RHYTHM PHARMACEUTICALS INC · Health Care

Catalio Capital Management, LP reported holding 85,614 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 1.52% of its reported portfolio and ranking #27 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.

Latest position (Q3 2026)85.61K sh
Reported value held$8.15M
Portfolio Weight1.52%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's RYTM position evolved

Catalio Capital Management, LP first disclosed a stake in RYTM in Q3 2026 at 85,614 shares (US$8.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 85.61K $8.15M New

About RYTM and 13F data

RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$634.8M), BAKER BROS. ADVISORS LP (US$533.6M), PERCEPTIVE ADVISORS LLC (US$241.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RYTM

All RYTM fund holders →

FAQ

How long has Catalio Capital Management, LP held RYTM?

Catalio Capital Management, LP has disclosed RYTM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Catalio Capital Management, LP's current position in RYTM?

As of Q3 2026, Catalio Capital Management, LP holds 85.61K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $8.15M, representing 1.52% of its reported portfolio and ranking #27.

Has Catalio Capital Management, LP been buying or selling RYTM?

In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in RYTM.

Which other funds hold RYTM?

Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.